Hakola, Leena http://orcid.org/0000-0001-7115-6035
Vuorinen, Anna-Leena http://orcid.org/0000-0002-5658-1305
Takkinen, Hanna-Mari
Niinistö, Sari
Ahonen, Suvi
Rautanen, Jenna
Peltonen, Essi J. http://orcid.org/0000-0002-5782-3089
Nevalainen, Jaakko http://orcid.org/0000-0001-6295-0245
Ilonen, Jorma http://orcid.org/0000-0002-9973-2062
Toppari, Jorma
Veijola, Riitta http://orcid.org/0000-0002-6557-270X
Knip, Mikael http://orcid.org/0000-0003-0474-0033
Virtanen, Suvi M. http://orcid.org/0000-0001-8928-0878
Funding for this research was provided by:
Academy of Finland
Emil Aaltosen Säätiö
Ella ja Georg Ehrnroothin Säätiö
European Foundation for the Study of Diabetes
Diabetesliitto
Diabetestutkimussäätiö
Juho Vainion Säätiö
JDRF
competitive state research financing of the expert responsibility area of Tampere University Hospital
Oulu University Hospital research funds
Turku University Hospital governmental grants
European Commission
Novo Nordisk Fonden
Sigrid Juséliuksen Säätiö
Article History
Received: 14 December 2021
Accepted: 11 October 2022
First Online: 25 October 2022
Declarations
:
: The authors have no competing interests to declare that are relevant to the content of this article.
: Data described in the manuscript, and analysis codes can be made available upon request considering the ethical and legislative restrictions.
: Written informed consent was obtained from the parents for genetic testing of their newborn infant from the cord blood sample and another one for participation in the follow-up. The study adheres to the Declaration of Helsinki, and the ethics committees of Oulu and Tampere University Hospitals approved the study protocol.